Sharonda Longino
Family · Valencia, CANPI 1861032757
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 248 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,069, more than ten times the $141 reported in 2021. Among family clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 248 payments — averaging $34.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Sanofi$1K
- Regeneron Healthcare Solutions, Inc.$994
- Galderma Laboratories, L.p.$743
- Dermavant Sciences, Inc.$535
- Arcutis Biotherapeutics, Inc.$431
- plus $3K from 19 others
What the payments were for
- Food & beverage$8,39998%
- Education$2102%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 48 | $1,654 |
| Sanofi | 27 | $1,062 |
| Regeneron Healthcare Solutions, Inc. | 24 | $994 |
| Galderma Laboratories, L.p. | 12 | $743 |
| Dermavant Sciences, Inc. | 11 | $535 |
| Arcutis Biotherapeutics, Inc. | 22 | $431 |
| Incyte Corporation | 9 | $402 |
| UCB, Inc. | 10 | $385 |
| Lilly USA, LLC | 18 | $380 |
| Pfizer | 15 | $338 |
| LEO Pharma Inc. | 14 | $275 |
| Johnson & Johnson | 3 | $234 |
| Amgen | 9 | $200 |
| Organon | 2 | $157 |
| Botanix SB Inc | 4 | $138 |
| Novartis | 3 | $131 |
| Merz North America, Inc. | 3 | $125 |
| Sun Pharmaceutical Industries Inc. | 4 | $90 |
| E.r. Squibb & Sons, L.L.C. | 1 | $84 |
| Revance Therapeutics, Inc. | 1 | $67 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $57 |
| Almirall LLC | 2 | $47 |
| Boehringer Ingelheim | 1 | $29 |
| Organogenesis Inc. | 1 | $26 |
| Journey Medical Corporation | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,608 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tacrolimus | 12 | $2,082 |
| Clobetasol Propionate | 35 | $1,725 |
| Ketoconazole | 55 | $643 |
| Triamcinolone Acetonide | 41 | $464 |
| Mupirocin | 44 | $326 |
| Doxycycline Hyclate | 18 | $187 |
| Minocycline Hcl | 11 | $100 |
| Hydrocortisone | 11 | $51 |
Paid to pharmacies, not to this prescriber.
Other family in Valencia
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.